SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Equipment >

InspireMD, Inc. (NSPR)

NSPR RSS Feed
Add NSPR Price Alert      Hide Sticky   Hide Intro
Moderator: pennystock_es
Search This Board: 
Last Post: 11/16/2017 3:54:38 PM - Followers: 54 - Board type: Free - Posts Today: 0

 

Great Europe-Patent News for NSPR (01.05.2017):
 https://register.epo.org/application?number=EP07827415

NSPR is still one of the Cheapest NYSE stocks based on the New BV & CV! The 10-Q confirms its 100% Debt-Free financial status which is the most important fundamental for a big board stock ! 

https://register.epo.org/application?number=EP07827415 
https://finance.yahoo.com/news/inspiremd-announces-distribution-agreement-cguard-113000992.html 
http://finance.yahoo.com/news/inspiremd-announces-distribution-agreement-cguard-110000931.html 
http://finance.yahoo.com/news/inspiremd-cguard-tm-embolic-prevention-133200180.html 
http://www.marketwatch.com/story/inspiremd-repays-term-note-ahead-of-schedule-2017-03-22?siteid=bigcharts&dist=bigcharts 


InspireMD was founded in 2005 with the purpose of creating a technology that could solve the problem of embolization in high risk vascular procedures. The company has grown to include a portfolio of embolic protection systems, which it both manufactures and commercializes.

Today, InspireMD is a global company headquartered in Boston, MA. InspireMD seeks to utilize its proprietary MicroNetTM technology to make its products the industry standard for embolic protection by providing a superior solution to the key clinical issues of vascular procedures.
 

Our Technology

MicroNetTM

The MicroNet is a bio-stable mesh woven from a single strand of 20 μm Polyethylene Terephthalate (PET). The MicroNet is designed to trap and seal thrombus and plaque against the vessel wall, preventing embolization.

MicroNetTM key features:

  • PET is a bio-stable synthetic fiber widely used in a variety of industries.
    Attached and secured to the proximal and the distal crowns of the stent.
    Does not alter the procedure as it expands with the stent.
    Pore size is typically between 150 – 180 µm. 
     

CGuard™

need for tapered version


Carotid Embolic Prevention System

The CGuardTM Embolic Prevention System (EPS) is designed to prevent peri-procedural and late embolization by trapping potential emboli against the arterial wall while maintaining excellent perfusion to the external carotid artery and branch vessels.

Product Details:

  • CGuard material: Nitinol
MicroNet material: Polyethylene Terephthalate (PET)
  • Easy to use RX (Rapid Exchange) delivery system
     

MGuard™

Improving Clinical Outcomes For STEMI Patients

The MGuardTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization and optimize flow.

While offering performance that is superior to standard STEMI therapy, MGuard requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard material: Stainless Steel 316 
  • MicroNet material: Polyethylene Terephthalate (PET)

     

MGuard Prime™

Improving Clinical Outcomes For STEMI Patients

The MGuard PrimeTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization, and optimize flow, while ensuring excellent deliverabililty.

While offering performance that is superior to standard STEMI therapy, MGuard Prime requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard Prime material: Cobalt Chromium (CoCr) L605

MicroNet material: Polyethylene Terephthalate (PET)
  • Superior flexibility and excellent deliverability

http://www.inspiremd.com/en/products/the-technology/
 

2017 News

Thursday23March 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at ICCA Stroke 2017 in Moscow, Russia

BOSTON, MA—March 23, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS), neurovascular devices and thrombus management technologies, today announced that its…

Wednesday22March 2017

InspireMD Repays Term Note Ahead of Schedule

Tel Aviv—March 22, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that…

Tuesday21March 2017

InspireMD Announces Distribution Agreement for CGuard™ EPS in Hong Kong

BOSTON, MA—March 21, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Monday20March 2017

InspireMD Announces CGuardTM Distribution Agreement for the Russian Federation

Tel Aviv—March 20, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Wednesday15March 2017

InspireMD Reports Continued Progress in the Transition of European Sales and Distribution

Announces Agreements with Leading Distributors in the Baltic States   BOSTON, MA—March 15, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS)…

Tuesday14March 2017

InspireMD Announces Closing of Public Offering of Approximately $6.8 Million

BOSTON, MA – March 14, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday09March 2017

InspireMD Announces Pricing of Public Offering of up to $7.5 Million

BOSTON, MA – March 9, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday16February 2017

InspireMD Provides Year End Business Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016

Transition from Exclusive Distribution Partner to Local Distributors and Internal Sales Strategy Validated by Strong Revenue Growth in Select Markets   BOSTON, MA—February 16, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS)…

Tuesday24January 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at LINC 2017

PD Dr. Andrej Schmidt to perform live case transmission of carotid stent surgery utilizing CGuard™ BOSTON, MA– January 24, 2016 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a…

Contact Us

Thank you for your interest in InspireMD, please let us know how we can help you. You can contact us at info@inspiremd.com or 1-888-776-6804.

Executives

James J. BarryPresident & Chief Executive Officer

Dr. Barry has over 20 years of experience in the medical device industry. Prior to joining InspireMD, he was the President and CEO of Arsenal Medical, a life sciences company…

Craig ShoreChief Financial Officer

Mr. Shore has over 25 years of experience in financial management in the United States, Europe and Israel. He has served in various senior financial and general management roles at…

Agustin GagoExecutive Vice President and Chief Commercial Officer

Mr. Gago has over 25 years of experience in building profitable international commercial, sales and marketing organizations. Prior to joining InspireMD, he was the founder and principal of Dash International…

Benzi SpectorHead of R&D and Operations

Mr. Spector has more than 25 years of experience in research, development and engineering, serving as the lead on a range of product lines and systems in the healthcare space….

Sharon ShacharHead of Regulatory and Quality

Mrs. Shachar has over 12 years of experience in quality, regulatory and clinical execution, serving in executive roles in small and large medical companies.   Prior to joining InspireMD, she…

Website:  http://www.inspiremd.com/en/

 

SureTrader
Interactive Brokers Advertisement
NSPR
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#1035   It SHOULD HAVE gotten thru .60 today, but Three2001 11/16/17 03:54:38 PM
#1034   Looks like it started breaking out today!!! .60 next!?!?! king koopa 11/15/17 08:26:41 PM
#1033   Still some buying after hours, topping the official Three2001 11/15/17 07:40:41 PM
#1032   LETS SEE WHAT NSPR BRINGS TOMORROW. otcmoneydoubler 11/15/17 06:58:10 PM
#1031   When will that 1:10 ~ 1:15 Big R/S Value_Investor 11/13/17 10:55:49 AM
#1030   Read the 10Q: Rymankoly 11/08/17 10:39:11 PM
#1029   Keeps exhibiting the same action. Nice move in Three2001 11/08/17 08:46:42 PM
#1028   I'm in total disbelief as well I thought king koopa 11/08/17 08:40:02 PM
#1027   Wow, what's up here, this should easily be Three2001 11/08/17 10:09:16 AM
#1026   Great earnings report!! Should see a new PT chriswolff 11/08/17 06:06:29 AM
#1025   $NSPR earnings/sales are up, liabilities are down, finally Three2001 11/07/17 05:21:49 PM
#1024   Nice uptrend since the beginning of September, pull king koopa 10/28/17 01:17:51 PM
#1023   To whom it may concern: Three2001 10/27/17 03:23:30 PM
#1022   No kidding! And the bid dropped to .39 king koopa 10/26/17 04:03:59 PM
#1021   What is up with this one? 4 or Three2001 10/26/17 03:54:47 PM
#1020   Seems like if it holds .40 then the king koopa 10/25/17 03:21:31 PM
#1019   Amazing how it can keep getting over 50c, Three2001 10/25/17 10:24:50 AM
#1018   Nice news this morning too and bid is king koopa 10/25/17 09:19:30 AM
#1017   Regains compliance with NYSE shurtha2000 10/24/17 11:07:33 AM
#1016   I would think this week will reveal if king koopa 10/22/17 09:24:56 PM
#1015   Yes, it is ridiculously undervalued, just by cash Three2001 10/13/17 07:12:58 PM
#1014   Bought some today at .43-.44.... been watching for king koopa 10/13/17 04:53:09 PM
#1013   Chile added to their list of distribution countries. Three2001 10/12/17 10:42:39 AM
#1012   More probably tomorrow I would think. Three2001 10/09/17 05:14:38 PM
#1011   * * $NSPR Video Chart 10-09-17 * * ClayTrader 10/09/17 04:42:12 PM
#1010   Ah, the recent volume showed news was coming, Three2001 10/09/17 11:30:29 AM
#1009   Keep the volume and turnaround going this Three2001 10/08/17 11:06:20 PM
#1008   Almost another million share day, it seems like Three2001 10/06/17 05:35:07 PM
#1007   Glad to see NSPR has formed Three Strong Value_Investor 10/06/17 10:30:11 AM
#1006   Anyway I voted all my shares (1M) against Rymankoly 10/02/17 11:12:36 AM
#1005   Beware the Key week for NSPR --- Big Value_Investor 10/02/17 10:30:04 AM
#1004   I think this will hit .50 early, but Three2001 09/28/17 10:26:27 PM
#1003   TIC TAC go $NSPR pennystock_es 09/28/17 11:55:07 AM
#1002   NSPR has already built three higher New lows Value_Investor 09/25/17 09:00:48 PM
#1001   I was just thinking the same thing. It Three2001 09/22/17 11:20:52 AM
#1000   The MMs are very very sick! They manipulated Value_Investor 09/22/17 11:17:38 AM
#999   Portugal news has been slightly helpful to the Three2001 09/21/17 05:25:28 PM
#998   NSPR has Good News today! Value_Investor 09/21/17 03:55:56 PM
#997   NEWS! out Contract Agreement! http://ih.advfn.com/p.php?pid=nmona&article=756996 bluredeyedspk 09/21/17 12:28:13 PM
#996   Yes, I keep expecting it to make another Three2001 09/20/17 03:10:32 PM
#995   NSPR can easily surge back to the Dollar Value_Investor 09/20/17 03:05:38 PM
#994   It seems those greedy shorters are in control Value_Investor 09/19/17 03:08:26 PM
#993   When will the next Big R/S kick in Value_Investor 09/18/17 10:29:35 AM
#992   What happened today? CH11 or even CH7 Bankruptcy Value_Investor 09/15/17 04:32:20 PM
#991   Last evening and this early morning NSPR ever Value_Investor 09/14/17 10:32:43 AM
#990   $NSPR Nice move today on over a million Three2001 09/13/17 07:23:40 PM
#989   Nice to see this hidden gem bounce 30% Value_Investor 09/13/17 03:00:14 PM
#988   This is NOT a pump and dump, geez, Three2001 09/12/17 07:16:45 PM
#987   Bad News to this pump and dump. Rymankoly 09/07/17 11:37:03 AM
#986   "The Barry Amendment provides that, in the event lugan 09/07/17 11:16:45 AM
PostSubject